Safety, Tolerability, and Pharmacokinetics of Recombinant Human Neuregulin-1 in Healthy Chinese Subjects.
Background: We investigated the safety, tolerability, and pharmacokinetics of intravenous recombinant human Neuregulin-1 (rhNRG-1), a DNA recombinant protein for the treatment of chronic heart failure, in healthy Chinese volunteers following single and multiple dose administration. Methods and Resul...
| Publicado en: | American Journal of Cardiovascular Drugs Vol. 23; no. 4; pp. 419 - 429 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | research tables/charts randomized controlled trial Journal Article |
| Publicado: |
Springer Nature
Jul2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |